Live Breaking News & Updates on Samuel Durand Professor

Stay updated with breaking news from Samuel durand professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'Promising' Treatments Identified for Older Adults with Hodgkin Lymphoma

Recent research has shown encouraging results for older patients with classical Hodgkin lymphoma treated with Adcetris plus chemotherapy or Opdivo. ....

Jonathanw Friedberg , Jamesp Wilmot Cancer Institute , University Of Rochester Medical Center , Cancer Institute , Samuel Durand Professor , Rochester Medical Center , Shows Promise , Adcetris Combo , Hodgkin Lymphoma , Classical Hodgkin Lymphoma ,

Relapsed DLBCL: Complete Interim Response, SCT Beats CAR T

'In patients with relapsed DLBCL in a complete remission, treatment with auto-HCT is associated with a lower rate of relapse/progression, and a longer progression-free survival [versus CAR T therapy].' ....

San Diego , United States , New York , University Of Rochester , Morphosys Incyte , Mazyar Shadman , Jonathanw Friedberg , Bristol Myers Squibb , American Society Of Hematology , International Blood Marrow Transplant Research , Division Of Medical Oncology , Wilmot Cancer Institute , University Of Washington , Medical Oncology , American Society , International Blood , Marrow Transplant Research , Samuel Durand Professor , Fate Therapeutics , Mustang Bio , Non Hodgkin Amp 039s Lymphoma , Non Hodgkin Lymphoma , Biologic Therapy , Chimeric Antigen Receptort Cell Therapy , Chimeric Antigen Receptors , Himeric Immunoreceptors ,